Target intelligence / Profile preview

Huntingtin protein mutant form (mHTT)

Target
mHTT
Molecular classification
Protein, Transcription factor
01

Overview

The mutant form of huntingtin protein (mHTT) arises from an expanded CAG trinucleotide repeat in the HTT gene, leading to an abnormally long polyglutamine tract. This causes Huntington’s disease (HD), characterized by motor dysfunction, psychiatric symptoms, and cognitive decline. mHTT aggregates, disrupts transcription, impairs DNA repair, activates apoptosis, and impairs intracellular trafficking, leading to neuronal dysfunction and neurodegeneration.

Other names
Mutant HuntingtinmHTTExpanded PolyQ Huntingtin
02

Mechanism of action

Inhibition of mHTT aggregation; modulation of splicing/expression levels

03

Biological functions

Protein aggregationTranscriptional dysregulationImpaired DNA repairApoptosis activationImpaired intracellular traffickingSynaptic dysfunction
04

Disease associations

Neurodegenerative diseaseHuntington's Disease
05

Safety considerations

Potential for off-target effectsDelivery to the brainLong-term effects of mHTT reduction/inhibition
06

Biomarkers

CAG repeat length in HTT gene

Beyond the preview

Go deeper on Huntingtin protein mutant form (mHTT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huntingtin protein mutant form (mHTT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call